MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-KL-02-0037353
Chemwel Pharma Limited
Chemwel Pharma Limited - trading in Ernakulam, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹59.56 Lakh
▼ 34% YoY
Net loss · FY 2025
₹31,000
Net margin -0.5%
EBITDA · FY 2025
₹2.03 Lakh
EBITDA margin 3.4%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹32.06 Lakh
Issued & subscribed
Company age
28 yrs
Est. 1998
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered
About Chemwel Pharma Limited
Data last updated:
Chemwel Pharma Limited is a public limited company based in Ernakulam, Kerala, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 26 February 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24231KL1998PLC012114. Its GSTIN is 32AABCC9972H1ZJ (Kerala).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹32.06 Lakh. It is led by directors including Joshy John (Managing Director) and Sreekanth Raveendran.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 46/1050 – A(1) Ushus Building Near Lic Office Chittor Road Vaduthala P.O., Ernakulam, Kerala, India – 682023.
As per the financials filed for FY 2025, the company reported a revenue of ₹59.56 Lakh, a decline of 34% compared to the previous year. For the same year it recorded a net loss of ₹31,000 (net margin -0.5%) and EBITDA of ₹2.03 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 3% over five years.
Court records list 3 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending.
Chemwel Pharma Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-02-0037353). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Chemwel Pharma Limited
CIN U24231KL1998PLC012114
Registration Number 012114
Incorporation Date 26 February 1998
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KL-02-0037353
Key People
Joshy John Managing Director Sreekanth Raveendran Director Soney Swamini Raveendran Director Recognitions & Rankings of Chemwel Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address46/1050 – A(1) Ushus Building Near Lic Office Chittor Road Vaduthala P.O., Ernakulam, Kerala, India – 682023
- IndustryTrading, Wholesale, Other Wholesale
Comprehensive company report
Chemwel Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Chemwel Pharma Limited
The main business activity of Chemwel Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Chemwel Pharma Limited FY 2025 filings available
Chemwel Pharma Limited reported revenue of ₹59.56 Lakh (down 34% YoY) for FY 2025.
Revenue · FY 2025
₹59.56 Lakh ▼ 34%
Net loss · FY 2025
₹31,000 margin -0.5%
EBITDA · FY 2025
₹2.03 Lakh margin 3.4%
Compounded Annual Growth Rate (CAGR) of Chemwel Pharma Limited
Revenue CAGR growth
1 year
▼ 34%
3 years · compounded
▼ 2%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 64%
3 years · compounded
▼ 18%
5 years · compounded
▼ 3%
Revenue fell 34% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Chemwel Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.03 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹31,000 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Chemwel Pharma Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Chemwel Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Chemwel Pharma Limited
Chemwel Pharma has 4 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Joshy John | Managing Director | 22 Nov 2013 | 12 Years 10 Months | Current |
| Sreekanth Raveendran | Director | 22 Nov 2013 | 12 Years 10 Months | Current |
| Soney Swamini Raveendran | Director | 23 Jul 2016 | 10 Years 2 Months | Current |
| Ratheesh Menon Pushpavenibalakrishna | Additional Director | 23 Nov 2019 | 6 Years 10 Months | Current |
Peer Comparison of Chemwel Pharma Limited
Chemwel Pharma Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Upkar Merchantry Private Limited | ₹60.14 Lakh (FY 2025) | •••• | •••• | 89.0% | •••• | New Delhi, Delhi, India |
| Franco Indian Medicare Pvt Ltd | ₹60.11 Lakh (FY 2024) | •••• | •••• | 17.0% | •••• | Kolkata, West Bengal, India |
| Nirmiti Pharmaceutical Private Limited | ₹60.05 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Pune, Maharashtra, India |
| Medicine Complex (India) Private Limited | ₹59.81 Lakh (FY 2024) | •••• | •••• | 704.0% | •••• | Agra, Uttar Pradesh, India |
| Scortis Pharma Limited | ₹59.59 Lakh (FY 2025) | •••• | •••• | -8.0% | •••• | Rajasthan, India |
| Chemwel Pharma Limited this company | ₹59.56 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | Ernakulam, Kerala, India |
| Polychem Formulations Private Limited | ₹59.55 Lakh (FY 2025) | •••• | •••• | 930.0% | •••• | Kanalpirivu, Kerala, India |
| Biogen Chemicals & Pharmaceuticals Private Limited | ₹59.47 Lakh (FY 2019) | •••• | •••• | 336.0% | •••• | Delhi, India |
| Scarllet Remedies Private Limited | ₹59.37 Lakh (FY 2025) | •••• | •••• | 465.0% | •••• | Khargone, Madhya Pradesh, India |
| Magdale Pharma Private Limited | ₹59.06 Lakh (FY 2024) | •••• | •••• | -83.0% | •••• | Mumbai, Maharashtra, India |
| Fornex Healthcare Private Limited | ₹59 Lakh (FY 2025) | •••• | •••• | -23.0% | •••• | Deepali, Pitampura, Delhi, India |
Peers are the five companies nearest above and the five nearest below Chemwel Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Chemwel Pharma Limited
Chemwel Pharma Limited is audited by K.P.VASUDEVAN for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K.P.VASUDEVAN | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Chemwel Pharma Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Chemwel Pharma Limited
Chemwel Pharma Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Chemwel Pharma Limited
Chemwel Pharma Limited has 3 court cases on record: 1 filed by Chemwel Pharma, 1 filed against it, 1 where it is another party. 1 case is pending and 2 are disposed. Status as checked between 28 Sep 2026 and 29 Sep 2026.
Total cases
3
Filed by the company
1
Filed against the company
1
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 1 |
| High courts | 1 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed against the company by Dr's Kindcare Pharmaceuticals | Pending |
| High Court of Kerala | Court case (Crl.MC) | Filed by the company against State of Kerala | Disposed |
| District court, Alappuzha, Kerala | Criminal case | Company is another party | Disposed |
Premium access
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Chemwel Pharma Limited
Employment history and EPFO contributions of people linked to Chemwel Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Chemwel Pharma Limited
Chemwel Pharma Limited has 23 board changes on record since 2009: 5 appointments and 18 cessations. The latest: Jaison Varghese ceased to be Director on 21 Nov 2024.
AGM
Chemwel Pharma Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Chemwel Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Ceased
Jaison Varghese ceased to be Director.
Ceased
Hareesh Raveendran ceased to be Director.
Ceased
Ranjith Kandamuthan ceased to be Director.
Appointed
Ratheesh Menon Pushpavenibalakrishna was appointed as Additional Director.
Ceased
Willy Davis Palocaren ceased to be Director.
Ceased
Dixon Syrass ceased to be Additional Director.
Ceased
Krishnan Rajagopalan ceased to be Director.
Ceased
Soney Swamini Raveendran ceased to be Additional Director.
Appointed
Soney Swamini Raveendran was appointed as Director.
Ceased
Renghu Peethambaran ceased to be Director.
14 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Chemwel Pharma Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Chemwel Pharma Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Chemwel Pharma Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Chemwel Pharma Limited
Chemwel Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AABCC9972H1ZJ | Kerala | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Chemwel Pharma Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chemwel Pharma Limited
Chemwel Pharma is an active public limited company based in Ernakulam, Kerala, India. The company works in wholesale, within the trading industry. It was incorporated on 26 February 1998 (28+ years old) and is registered under CIN U24231KL1998PLC012114.
Chemwel Pharma reported revenue of ₹59.56 Lakh for FY 2025 (down 34% YoY).
Chemwel Pharma has 4 current directors:
- Joshy John - Managing Director
- Sreekanth Raveendran - Director
- Soney Swamini Raveendran - Director
- Ratheesh Menon Pushpavenibalakrishna - Additional Director
Chemwel Pharma reported a net loss of ₹31,000 (net margin -0.5%) and EBITDA of ₹2.03 Lakh (EBITDA margin 3.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Chemwel Pharma is -2% over three years and 3% over five years. In the latest year (FY 2025) revenue fell 34%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Chemwel Pharma is 32AABCC9972H1ZJ, registered in Kerala.
The CIN (Corporate Identification Number) of Chemwel Pharma is U24231KL1998PLC012114. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Chemwel Pharma has 3 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.
Chemwel Pharma was incorporated on 26 February 1998, making it 28+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Chemwel Pharma by revenue are Upkar Merchantry Private Limited, Franco Indian Medicare Pvt Ltd, Nirmiti Pharmaceutical Private Limited, Medicine Complex (India) Private Limited, Scortis Pharma Limited and 5 more, all in the Pharma industry (Formulations).
Jaison Varghese ceased to be Director on 21 Nov 2024. Hareesh Raveendran ceased to be Director on 19 Jun 2020. Ranjith Kandamuthan ceased to be Director on 19 Jun 2020. Chemwel Pharma has 23 board changes on record in total.